Estructura del grupo
4 empresas en 2 países
Estados Unidos3
Singapur1
Prognia forma los grupos a partir de los nombres que publican las autoridades reguladoras y de los vínculos entre empresas; no son una estructura societaria oficial.
Medicamentos
Todos los medicamentos de todas las empresas del grupo, primero los vigentes.
15 medicamentos
| Medicamento | Principio activo | País | Estado | Autorización |
|---|---|---|---|---|
| AKOVAZ25mg/5ml (5mg/ml) | 50mg/ml (50mg/ml) · Solution | Ephedrine | Estados Unidos | Comercializado | 2016 |
| ANEXTROZOLE FILM-COATED TABLET 1 mg1.0mg · Tablet, film coated | Anastrozole | Singapur | Autorizado | 2017 |
| BLOXIVERZ10mg/10ml (1mg/ml) | 5mg/10ml (0.5mg/ml) | 5mg/5ml (1mg/ml) · Solution | Neostigmine | Estados Unidos | Comercializado | 2013 |
| CAFFEINE CITRATE30mg base/3ml (eq 10mg base/ml) · Solution | Caffeine | Estados Unidos | Comercializado | 2006 |
| DILTIAZEM HYDROCHLORIDE IN DEXTROSE 5%125MG/125ML (1MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 250MG/250ML (1MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Solution | Diltiazem | Estados Unidos | No comercializado | 2021 |
| ELCYS2500mg/50ml (50mg/ml) | 500mg/10ml (50mg/ml) · Solution | Cysteinum | Estados Unidos | Comercializado | 2019 |
| FENTANYL CITRATE2.5MG BASE/50ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 5MG BASE/100ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Solution | Fentanyl | Estados Unidos | No comercializado | 2023 |
| GANZYK-RTU500mg/250ml (2mg/ml) · Solution | Ganciclovir | Estados Unidos | No comercializado | 2017 |
| GLYRX-PF0.2mg/ml (0.2mg/ml) | 0.4mg/2ml (0.2mg/ml) | 0.6mg/3ml (0.2mg/ml) | 1mg/5ml (0.2mg/ml) · Solution | Glycopyrronium | Estados Unidos | Comercializado | 2018 |
| MIDAZOLAM IN 0.8% SODIUM CHLORIDE100MG/100ML (1MG/ML) | 50MG/50ML (1MG/ML) | 50MG/50ML (1MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Solution | Midazolam | Estados Unidos | Comercializado | 2022 |
| NIPRIDE RTU IN SODIUM CHLORIDE 0.9%10MG/50ML (0.2MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | 20MG/100ML (0.2MG/ML) | 50MG/100ML (0.5MG/ML) · Solution | Nitroprusside | Estados Unidos | Comercializado | 2017 |
| POTASSIUM ACETATE2meq/ml · Injectable | Potassium acetate | Estados Unidos | Comercializado | 1984 |
| VAZCULEP100mg/10ml (10mg/ml) | 10mg/ml (10mg/ml) | 50mg/5ml (10mg/ml) · Solution | Phenylephrine | Estados Unidos | No comercializado | 2014 |
| ARIGAL 250MG/2.5ML | Argatroban | Arabia Saudí | Autorizado | |
| ARIGAL 50MG/50ML | Argatroban | Arabia Saudí | Autorizado |